Über das Unternehmen
- Firmenname (rechtlich): Abydos Pharma
- Internationaler Name: Abydos Pharma, China
- Marke / Handelsname: Abydos Pharma
- Registrierungsland: China
- Adresse: JiangsuNanjing699-8 Xuanwu Avenue, Nanjing • Jiangsu
Beschreibung:
Abydos Pharma is a Nanjing-based manufacturer specializing in pharmaceutical intermediates, fine chemicals, amino acid derivatives and other active pharmaceutical ingredients, complemented by pharmaceutical excipients and CDMO-style outsourcing, custom synthesis and consulting services. The company ships to customers across Asia, North and South America, Western and Eastern Europe, Australasia, the Middle East and Africa, and is built around an experienced R&D team and production capacity that can accommodate buyers' specific requirements, underpinning its reputation for reliable, high-quality service.
Geschäftsaktivitäten
Pharmazeutische Chemikalien
LieferantAnbieter für AuftragssyntheseHersteller
Pharmazeutische Wirkstoffe (API)
API-HerstellerHersteller
Hilfsstoffe & Zusatzstoffe
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Exatecan mesylate, MMAE, Tirzepatide, Semaglutide, Carfilzomib, Retatrutide, Belotecan HCl, Eribulin, N-Boc-dolaproine, SNAC
- Pharmazeutische Chemikalien: (alphaS)-alpha-[(4-Morpholinylacetyl)aMino]benzenebutanoyl-L-leucyl-L-phenylalanine(Carfilzomib intermediate), ((1S)-3-Methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester(Carfilzomib intermediate), (2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone Trifluoroacetate(Carfilzomib intermediate), Boc-His(Trt)-Aib-Glu(OBtu)-Gly-OH(Semaglutide Main Chain), Boc-His(Trt)-Aib-OH(Semaglutide Main Chain), Boc-Tyr(tBu)-Aib-Gln(Trt)-Gly-OH(Retatrutide Main Chain), Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OH(Tirzepatide Main Chain), Boc-Tyr(tBu)-Aib-OH(Tirzepatide Main Chain), C20-γ-Glu(AEEA-AEEA-OSu)-OH(Tirzepatide intermediate), C20-OtBu-Glu(OtBu)-AEEA-AEEA-OH(Tirzepatide intermediate), C20-OtBu-Glu(OtBu)-AEEA-OH(Retatrutide intermediate), C20(OtBu)-Glu-OtBu(Tirzepatide intermediate), Eribulin Fragment B Alcohol, Eribulin Fragment C, Eribulin intermediate (C14-C35), Fmoc-His-Aib-OH.TFA(Semaglutide Main Chain), Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH(Tirzepatide intermediate), Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA]-OH(Retatrutide intermediate), Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH(Semaglutide intermediate), H-AEEA-AEEA-OH(Tirzepatide intermediate), Semaglutide intermediate P27, Semaglutide intermediate P29, Ste-Glu-AEEA-AEEA-OSU(Semaglutide intermediate), tBuO-Ste-γGlu(OtBu)-AEEA- AEEA-OH(Semaglutide intermediate), Tirzepatide intermediate P10, Tirzepatide Intermediate P14, Tirzepatide Intermediate P7, Tirzepatide intermediate P8Tirzepatide intermediate P8
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen